Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
7 Leser
Artikel bewerten:
(0)

High-Dose Lipitor(R) Reduces Heart Attack and Stroke by One-Third In Patients With Chronic Kidney Disease, New Analysis Shows


NEW YORK, November 15 /PRNewswire/ -- THIS IS A MULTIVU SPECIAL REPORT BROUGHT TO YOU BY PFIZER.

ABOUT 20 MILLION AMERICANS HAVE CHRONIC KIDNEY DISEASE, A CONDITION IN WHICH THE KIDNEYS DO NOT EFFECTIVELY FILTER TOXINS FROM THE BLOOD. PEOPLE WITH CHRONIC KIDNEY DISEASE ARE MORE LIKELY TO DIE FROM HEART DISEASE THAN TO DEVELOP KIDNEY FAILURE.

A NEW ANALYSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE FROM A LARGER STUDY OF PATIENTS WITH HEART DISEASE SHOWED TAKING 80 MILLIGRAMS OF LIPITOR REDUCED THEIR RISK OF A HEART ATTACK OR STROKE BY 32 PERCENT COMPARED WITH THOSE TAKING A 10 MILLIGRAM DOSE. THE RESULTS WERE PRESENTED AT THE AMERICAN HEART ASSOCIATION MEETING.

DOCTOR JOHN LAROSA, PRESIDENT AND PROFESSOR OF MEDICINE, SUNY DOWNSTATE MEDICAL CENTER:

"These findings indicate that more aggressive treatment with Lipitor in patients with kidney disease can help reduce the risk of heart attack and stroke. Moreover, this analysis demonstrates that high dose Lipitor produces both a reduction in cardiovascular events and an improvement in measures of kidney function in patients with chronic kidney disease and heart disease."

FOR MORE INFORMATION, VISIT LIPITOR.COM I'M LARRY CARDARELLI. Important Safety Information

LIPITOR IS A PRESCRIPTION MEDICATION. IT IS USED IN PATIENTS WITH MULTIPLE RISK FACTORS FOR HEART DISEASE SUCH AS FAMILY HISTORY, HIGH BLOOD PRESSURE, AGE, LOW HDL ("GOOD" CHOLESTEROL) OR SMOKING TO REDUCE THE RISK OF HEART ATTACK AND STROKE. WHEN DIET AND EXERCISE ALONE ARE NOT ENOUGH, LIPITOR IS USED ALONG WITH A LOW-FAT DIET AND EXERCISE TO LOWER CHOLESTEROL.

LIPITOR IS ALSO USED IN PATIENTS WITH TYPE 2 DIABETES AND AT LEAST ONE OTHER RISK FACTOR FOR HEART DISEASE SUCH AS HIGH BLOOD PRESSURE, SMOKING OR COMPLICATIONS OF DIABETES, INCLUDING EYE DISEASE AND PROTEIN IN URINE, TO REDUCE THE RISK OF HEART ATTACK AND STROKE.

LIPITOR IS NOT FOR EVERYONE. IT IS NOT FOR THOSE WITH LIVER PROBLEMS. AND IT IS NOT FOR WOMEN WHO ARE NURSING, PREGNANT OR MAY BECOME PREGNANT.

PATIENTS TAKING LIPITOR SHOULD TELL THEIR DOCTORS IF THEY FEEL ANY NEW MUSCLE PAIN OR WEAKNESS. THIS COULD BE A SIGN OF RARE BUT SERIOUS MUSCLE SIDE EFFECTS. PATIENTS SHOULD TELL THEIR DOCTORS ABOUT ALL MEDICATIONS THEY TAKE. THIS MAY HELP AVOID SERIOUS DRUG INTERACTIONS. DOCTORS SHOULD DO BLOOD TESTS TO CHECK LIVER FUNCTION BEFORE AND DURING TREATMENT AND MAY ADJUST THE DOSE. THE MOST COMMON SIDE EFFECTS ARE GAS, CONSTIPATION, STOMACH PAIN AND HEARTBURN. THEY TEND TO BE MILD AND OFTEN GO AWAY.

AUDIO PROVIDED BY: Pfizer
Audio: http://www.prnewswire.com/broadcast/26000/consumer.html

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2006 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.